Teva Recalls Metoclopramide Injection Due to Sterility Concerns
Teva Pharmaceuticals is recalling specific lots of Metoclopramide Injection because there is a lack of assurance of sterility. The product was distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls involving significant risks such as sterility issues in injectable drugs are categorized as Severe (Score 4), particularly when hospitalization reports or significant injury risks are implied by the nature of the defect.
Plain-English summary
Teva Pharmaceuticals USA is recalling Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vials. The recall is due to a lack of assurance of sterility. The affected product is identified by Lot # 31325459B with an expiration date of 08/2021.
The product was distributed nationwide. It is a prescription-only medication manufactured by TEVA Parenteral Medicines, Inc. in Irvine, CA. The specific NDC for the recalled packaging is 0703-4502-04.
Healthcare providers and patients should check their inventory and medication vials for the specific lot number and expiration date listed above. If the product matches the recalled lot, it should not be used. Patients should contact their healthcare provider for guidance on alternative treatments or further instructions.
The recalled product
- Product
- METOCLOPRAMIDE (METOCLOPRAMIDE)
- Brand
- METOCLOPRAMIDE
- Manufacturer
- Teva Pharmaceuticals USA
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 31325459B
- exp. date 08/2021
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Teva Pharmaceuticals USA under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same brand · METOCLOPRAMIDE
- SevereMetoclopramide Tablets Recalled for Presence of Foreign Tablets
FDA (Drugs) · 2025-07-02
- SevereMetoclopramide Injection Vials Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-08-25
- HighTeva Recalls Metoclopramide Injection Due to Chemical Contamination
FDA (Drugs) · 2021-03-10
- SevereTeva Recalls Metoclopramide Injection Due to Sterility Concerns
FDA (Drugs) · 2021-03-03
- SevereHospira Recalls Metoclopramide Injection Due to Glass Particulate Matter
FDA (Drugs) · 2013-11-27
Same manufacturer · Teva Pharmaceuticals USA
See all →- ModerateDoxylamine Succinate and Pyridoxine Hydrochloride Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-02-09
- LowPrescription Drug Recall: Mimvey Mislabeling by Teva Pharmaceuticals
FDA (Drugs) · 2022-02-09
- LowMimvey Estradiol/Norethindrone Prescription Drug Mislabeling Recall
FDA (Drugs) · 2022-02-09
- ModerateTretinoin Capsules 10 mg Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2022-02-09
- ModerateBrinzolamide Ophthalmic Suspension recalled for defective container caps
FDA (Drugs) · 2022-01-26
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29